Asep Inc. Signs Letter of Intent for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa by asepadmin | Jan 6, 2023 | Uncategorized
CLARIFICATION Asep Medical Holdings Inc. Provides Update on its Prior Disclosure Regarding Proprietary Diagnostic & Therapeutic Technologies by asepadmin | Dec 28, 2022 | Uncategorized
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies by asepadmin | Dec 24, 2022 | Uncategorized
Asep Inc. Completes Non-Brokered Private Placement of a $330,000 Unsecured Convertible Debenture by asepadmin | Dec 22, 2022 | Uncategorized
Asep Medical Holdings Inc. Enters into Commercial Agreement to Acquire SafeCoat Medical Inc. by asepadmin | Dec 2, 2022 | Uncategorized
Asep Medical Holdings Inc. Announces Grant of Stock Options by asepadmin | Nov 24, 2022 | Uncategorized
